CN109943564A - The gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh and its application - Google Patents
The gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh and its application Download PDFInfo
- Publication number
- CN109943564A CN109943564A CN201910240778.2A CN201910240778A CN109943564A CN 109943564 A CN109943564 A CN 109943564A CN 201910240778 A CN201910240778 A CN 201910240778A CN 109943564 A CN109943564 A CN 109943564A
- Authority
- CN
- China
- Prior art keywords
- mouse
- amh
- cre
- positive
- knocking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses the gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh and its applications.The available hybrid mice model of the construction method through the invention provides effective experimental animal model for the research of POF pathogenesis and medicament research and development and evaluating drug effect.The present invention provides application of the gene site-directed hybrid mice model for knocking in 2A-Cre of Amh in screening preparation detection/treatment reproductive development disease medicament, detection/treatment disease of ovary drug and gonad granulocyte aging and apoptosis disease medicament.The present invention provides the construction method of the gene site-directed hybrid mice model for knocking in 2A-Cre of Amh for the first time, has no any domestic and foreign literature report before this.With good clinical medicine application prospect, there is very big application value in preparation detection/treatment disease of ovary drug, there is biggish social benefit.
Description
Technical field
The present invention relates to biotechnologys, and in particular to the gene site-directed hybrid mice model construction for knocking in 2A-Cre of Amh
Method and its application.
Background technique
Gonad granulocyte is of great significance to follicular development maturation as sertoli cell.But gonad granulocyte
Mechanism of action is still not clear.AMH, i.e., anti-gyneduct hormone, is secreted by gonad granulocyte, is had and is adjusted follicle cell development
And the effect of differentiation.Due to currently, constraining ovary hair without gonad granulocyte internal specific Cre transgenosis tool mouse
Educate the progress with functional study.Amh gene: anti-mullerian duct hormone (anti-Mullerian hormone, AMH) is conversion life
One of the member of long factor beta superfamily, by two identical 70KD subunits, the dimerization glycoprotein being made up of disulfide bond connection,
Relative molecular mass is 140KD;Mankind's AMH encoding gene is located at No. 19 the short arm of a chromosome, and 2.4~2.8kb of size contains 5
Exon.2A-Cre: segment name.The present inventor pinpoints 2A-Cre gene using CRISPR/Cas9 technology building 3 ' UTR of AMH
Knock in mouse model.Effective reality is provided for reproduction phenogenetics and disease of ovary research and medicament research and development and evaluating drug effect
Test animal model.
Summary of the invention
Technical problem to be solved by the present invention lies in above-mentioned shortcoming is overcome, researching and designing Amh is gene site-directed to be struck
Enter hybrid mice model and its construction method and the application of 2A-Cre.
Target gene title (No. MGI): Amh (MGI:88006)
Target gene MGI website links: http://www.informatics.jax.org/marker/MGI:88006 mesh
Gene Ensembl website links: http://asia.ensembl.org/Mus_musculus/Gene/Summary? g=
ENSMUSG00000035262;R=10:80805248-80807648;The transcript that t=ENSMUST00000036016 is directed to
(No. Ensembl): Amh-201 (ENSMUST00000036016.5)
Knock in position: at terminator codon
Knock in segment name: 2A-Cre-polyA
The present invention provides the gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh, this method are as follows: benefit
With CRISPR/Cas9 technology, by way of homologous recombination, fixed point knocks in 2A-Cre- at Amh gene end codon
PolyA expression cassette.
The gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh provided by the invention, the mouse is such as
Amino acid sequence shown in SEQ ID NO.1
Specifically, the gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh of the present invention includes following step
It is rapid:
(1) by way of in-vitro transcription, Cas9mRNA and gRNA is obtained;
(2) determine that site where the Amh gene on No. 5 and No. 3 chromosomes of mouse is site1 as shown in SEQ ID NO:1;
The design recognition site of gRNA1 is designed as shown in SEQ ID NO:2 and SEQ ID NO:3;
(3) expression vector of building expression gRNA1;Homologous recombination is constructed by the method for In-Fusion cloning to carry
Body (donor vector), the carrier include 5 ' homology arm of 4.7kb, 3 ' homology arm of 1.4kb 2A-Cre-polyA and 4.3kb;
(4) by Cas9mRNA, gRNA and vector supplier microinjection into the fertilized eggs of C57BL/6J mouse, F0 generation is obtained
Mouse is identified through Long fragment PCR, obtains the F0 of 3 correct homologous recombinations altogether for mouse;
(5) F0 is for mouse and C57BL/6J mouse (the mouse strain of nineteen twenty-one Little Abby Lathrop, female mice
No. 57 mate with male mice 52 obtained by C57BL, be " standard " inbred mouse) to obtain 10 positive F1 generations small for mating
Mouse.
What the present invention finally obtainedF1 generation mouseFor C57BL/6J-Amhem(2A-Cre)2Smoc。
Correlation english note herein:
MRNA: mRNA, a chain by DNA instruct protein as from template transcription, carrying hereditary information
A kind of singlestranded RNA of synthesis.
GRNA: guide RNA, it acts in kinetoplast body in a kind of rear transcription modification for being known as rna editing, it can be with
Pre-mRNA pairing, and it is inserted into some uracils (U) wherein, it generates and has effective mRNA.The RNA of guide rna editing points
Son, length are about 60~80 nucleotide, are the tails by individual genetic transcription, with 3' oligomerization U, centre has one section
With by the sequence of editor's mRNA exact complementarity, the end 5' is an anchor series, it is complementary with unedited mRNA sequence.
In-Fusion cloning: being the In-Fusion patent enzyme of Clontech, this enzyme passes through identification DNA fragmentation and line
DNA fragmentation and linearized vector are efficiently accurately fused together by the 15bp homologous sequence of property carrier end.
Donor vector: vector supplier
C57BL/6J mouse: the mouse strain of nineteen twenty-one Little Abby Lathrop, it is female mice 57 small with male
C57BL obtained by mouse No. 52 mating is " standard " inbred mouse
F0 is for mouse: Primary mouse
F1 generation mouse: generation mice is bred by F0 for mouse.
Further, the gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh of the present invention includes following
Step:
(1) by way of in-vitro transcription, Cas9mRNA and gRNA is obtained;Fig. 1
(2) determine that site where the Amh gene on No. 5 and No. 3 chromosomes of mouse is site1 as shown in SEQ ID NO:1,
Sequence table 2,
The design recognition site of gRNA1 is designed as shown in SEQ ID NO:2 and 3, the former is sequence table 3, and the latter is sequence
Table 4;
Knock in site upstream and downstream sequence information
Before 2A-Cre coexpression structure fixed point is inserted into terminator codon.For the 5th exon design primer of Amh
RNA。
Exon5 Partial sequence information is following (being written as code area greatly, small to be written as 3 ' downstream sequences):
Site 1 (site 1)
CATCCCGGAGACCTACCAAGCCAACAACTGCCAAGGCGCCTGCGCGTGGCCGCAGTCTGACCGTAATC
CGCGCTACGGGAACCACGTGGTGCTGCTGCTAAAAATGCAGGCTCGCGGGGCTGCCCTGGGCCGCCTGCCCTGCTG
CGTGCCCACTGCCTACGCGGGCAAGCTGCTCATCAGCCTGTCCGAGGAGCGCATCAGCGCGCACCACGTGCCCAAC
ATGGTAGCCACCGAGTGCGGCTGCCGGTGAcgcccgccctcctcctcccctccccccccccccccgcccccagtca
gcgccctaataaagatcagcaaacactcagctggggtatctgtgggtggaggaaactcctgtcaacctcccttctg
The target sequence of suitable design guide-RNA in the above-mentioned sequence of gaatgcaaggcctgagtccttcccatccagccccta:
SEQ ID NO:2
Guide#1AACATGGTAGCCACCGAGTG CGG
SEQ ID NO:3
Guide#2TCACCGGCAGCCGCACTCGG TGG
Result (Fig. 2, table 2) is transcribed in vitro in Cas9 and gRNA
Table 1
gRNA | Sequence (5 ' -3 ') |
gRNA1 | AACATGGTAGCCACCGAGTG GGG |
gRNA2 | TCACCGGCAGCCGCACTCGG TGG |
Fig. 2: Cas9, gRNA electrophoresis result is transcribed in vitro.
Table 2
(3) homologous recombination plasmid construction
Homologous recombination plasmid map (see Fig. 3, table 3)
Fig. 3: homologous recombination vector plasmid map
Table 3
Homologous recombination plasmid enzyme restriction identifies (see Fig. 4)
Fig. 4: electrophoretogram is identified in homologous recombination vector digestion.B:BamHI digestion qualification result, theoretical stripe size are
9.1kb,5.8kb,1.3kb;M:1kb DNA ladder.
Fig. 5: homologous recombination positive mice PCR qualification program:
5 ' arm homologous recombination positive gene groups should amplify 5.5kb segment, and negative genes group is without product;3 ' arm homologous recombinations
Positive gene group should amplify 5.3kb segment, and negative genes group should amplify 11.1kb segment.
(4) F0 is identified for murine genes type
Through fertilized eggs microinjection, the present invention obtains 16 F0 for mouse altogether.By way of Long fragment PCR, to F0 generation
The genotype of mouse is identified that PCR result confirms through sequencing, which obtains the positive F0 generation of 3 correct homologous recombinations altogether
Mouse;
Homologous recombination positive mice PCR qualification program:
5 ' arm homologous recombination positive gene groups should amplify 5.5kb segment, and negative genes group is without product;3 ' arm homologous recombinations
Positive gene group should amplify 5.3kb segment, and negative genes group should amplify 11.1kb segment;
Homologous recombination positive F0 is for mouse PCR qualification result:
The F0 of the both arms homologous recombination positive is 6,7, No. 8 for mouse, and Long fragment PCR identifies that electrophoresis result is as shown in Figure 5:
Fig. 5: homologous recombination positive F0 identifies electrophoretogram for mouse PCR.6,7,8 be the positive.
Homology arm recombinates positive F0 for mouse PCR identification method: (table 4)
Table 4
Primer | Sequence 5'-- > 3' | Primer type |
I | CTCCTTTCTCTTTGCAGGGG | Forward |
II | GCATCTTCCAGGTGTGTTCA | Reverse |
Reaction system:
Reaction component | Volume (μ l) |
ddH2O | 13.2 |
Gxl PCR Buffer | 2 |
2.5mMdNTP | 2 |
Primer I(10pmol/μl) | 0.5 |
Primer II(10pmol/μl) | 0.5 |
Gxl DNA Polymerase* | 0.8 |
Tail genomic DNA | 1 |
Total | 20 |
* PrimeStar GXL (TaKaRa, Code No:R050A)
Reaction condition:
Homology arm recombinates positive F0 for mouse PCR identification method: table 5
Primer | Sequence 5'-- > 3' | Primer type |
III | TGTGTGCTCTGGGAATGACC | Forward |
IV | AAGAGTGACAGCCAGAAGCC | Reverse |
Reaction system:
Reaction component | Volume (μ l) |
ddH2O | 13.2 |
Gxl PCR Buffer | 2 |
2.5mMdNTP | 2 |
Primer I(10pmol/μl) | 0.5 |
Primer II(10pmol/μl) | 0.5 |
Gxl DNA Polymerase* | 0.8 |
Tail genomic DNA | 1 |
Total amount | 20 |
* PrimeStar GXL (TaKaRa, Code No:R050A)
Reaction condition:
(5) acquisition of F1 generation mouse and genotype identification
F0 mates for positive mice with wild type C57BL/6J mouse, and breeding obtains F1 generation mouse.It identifies and is sequenced through PCR
Confirmation obtains positive F1 generation mouse 3, number are as follows: 2,3, No. 4 altogether;
5 ' and 3 ' homology arm PCR of F1 generation mouse identification
PCR identifies that strategy and method identify part for mouse with F0, and 5 ' and 3 ' homology arm PCR of F1 generation mouse identifies electrophoresis knot
Fruit is as shown in Figure 6.PCR identifies positive mice are as follows: No. 2,3,4,10,11,13,14,15,16,22;It is sun through sequencing confirmation
Property;
Fig. 6: 5 ' homology arm of F1 generation mouse (5 ' arm) and 3 ' homology arms (3 ' arm) PCR identify electrophoretogram.
(number: F1 generation mouse number;WT: wild type control;M:1kb DNA ladder)
Upper figure: 5arm identifies electrophoretogram
The following figure;3arm identifies electrophoretogram
F1 generation mouse PCR identification sequencing comparison result
F1 generation positive mice PCR identifies product sequencing, has carried out 4 sequencing reactions altogether.The corresponding region of sequencing reaction,
In, 5 ' homology arms identification, PCR product sequencing has carried out 2 sequencing reactions altogether, is respectively labeled as: 1,2;The identification of 3 ' homology arms,
PCR product sequencing has carried out 2 sequencing reactions altogether, is respectively labeled as: 3,4.
1# sequencing reaction comparison result is shown in Fig. 9:
2# sequencing reaction comparison result is shown in Figure 10;
3# sequencing reaction comparison result is shown in Figure 11;
4# sequencing reaction comparison result, is shown in Figure 12;
Query is purpose sequence (Amh KI recombinated genomic DNA sequence), and Subject is to survey
Sequence result.
F1 generation positive mice number and essential information
F1 generation positive mice number and essential information are shown in Table 6.
Table 6:F1 is for positive mice essential information
The mouse that the present invention finally obtains is C57BL/6J-Amhem(2A-Cre)2Smoc
(3) PCR is identified
Table 7
It is a further object of the present invention to provide the gene site-directed heterozygote for knocking in 2A-Cre of construction method Amh of the present invention is small
Application of the mouse model in screening preparation detection/treatment reproductive development disease medicament.
Provide mouse model the answering in screening preparation detection/treatment disease of ovary drug that the construction method obtains
With.
It provides the mouse model that the construction method obtains and prepares the aging of detection/treatment gonad granulocyte in screening
With the application in apoptosis disease medicament.
The present invention provides small using CRISPR/Cas9 technology building 3 ' UTR of AMH fixed point 2A-Cre gene knock-in for the first time
Mouse model has no any domestic and foreign literature report.The mouse model of the method for the present invention building is reproduction phenogenetics and preparation
Detection/treatment disease of ovary drug and related drugs screening provide effective experimental animal model, and there is good medicine to face
Bed application prospect has very big application value in preparation detection/treatment disease of ovary drug, there is biggish social benefit.
Detailed description of the invention
Fig. 1: by way of in-vitro transcription, Cas9mRNA and gRNA is obtained;Pass through the method for In-Fusion cloning
Construct homologous recombination vector (donor vector), the carrier include 5 ' homology arm of 4.7kb, 1.4kb 2A-Cre-polyA and
3 ' homology arm of 4.3kb
Fig. 2: Cas9, gRNA electrophoresis result is transcribed in vitro
Fig. 3: homologous recombination vector plasmid map
Fig. 4: electrophoretogram B:BamHI digestion qualification result is identified in homologous recombination vector digestion, and theoretical stripe size is
9.1kb,5.8kb,1.3kb;M:1kb DNA ladder.
Fig. 5: homologous recombination positive F0 identifies that electrophoretogram 6,7,8 is positive, M:1kb DNA marker Fig. 6 for mouse PCR:
5 ' homology arm of F1 generation mouse (5 ' arm) and 3 ' homology arms (3 ' arm) PCR identification electrophoretogram (number: F1 generation mouse number;WT: wild
Raw type control;M:1kb DNA ladder)
Fig. 7: F1 generation mouse PCR product sequence verification schematic diagram
Fig. 8: gene knock-in mouse process is established using CRISPR/Cas9 technology
Fig. 9: 1# sequencing reaction comparison result:
Figure 10: 2# sequencing reaction comparison result:
Figure 11: 3# sequencing reaction comparison result:
Figure 12: 4# sequencing reaction comparison result.
Specific embodiment
The raw materials and reagents that embodiment uses unless otherwise stated, by being commercially available.
Embodiment 1
One, experimental animal
The C57BL/6 type mouse (weight is in 18 ± 2g) of 5 week old health, male and female each 100, by Shanghai south model organism
Science and Technology Co., Ltd. provides, and can reach 6 week old of requirement of experiment after a week through isolated rearing;6~8 week old health
ICR mouse 60, half male and half female, weight is purchased from Shanghai south model organism Science and Technology Co., Ltd. in 24 ± 2g, and mouse is equal
It is fed under SPF grades of environment, in strict accordance with animal house administrative provisions, guarantees daily temperature at 22 DEG C, humidity 40%~60% is moved
Light application time and interlunation are fifty-fifty in object room, and all relevant operation processing of zoopery follow strictly animal center related management
Regulations.
Two, experiment reagent
Cas9Nuclease (U.S. NEB);Premix TaqTM PCR enzyme (TAKARA Japan);DNA purification and recovery reagent
Box (Tianjin TIANGEN China);Injection Cas9mRNA (the biology China difficult to understand of Beijing hundred);Short interfering RNA purification kit
(U.S. Invitrogen);Pregnant mare serum (PMSG), human chorionic gonadotrophin (hCG) (China, Ningbo the second hormone factory);
KSOM culture solution (U.S. Millipore);Hyaluronidase, M2, KSOM culture medium (U.S. Sigma);Mouse gene group DNA mentions
Take kit (the good really China in Chengdu);Chloraldurate (the good source China in Zhejiang).
Three, experimental method
1.Cas9mRNA, gRNA and donor vector preparation
By way of in-vitro transcription, Cas9mRNA and gRNA is obtained;It is constructed by the method for In-Fusion cloning
Homologous recombination vector (donor vector), the carrier include 5 ' homology arm of 4.7kb, 1.4kb2A-Cre-polyA and 4.3kb
3 ' homology arms;As shown in Figure 1.
2.C57BL/6 donor female mice fertilized eggs prepare
(1) PMSG 5IU is injected intraperitoneally to donor female mice between 17:00~18:30 in afternoon.
After (2) 48 hours, hCG (10IU/mL) 0.5mL is injected intraperitoneally to every female mice, by after injection female mice and male mouse
It is mated, morning next day, 10:00 chose bolt.
(3) it takes off neck execution donor and sees bolt female mice, take its fallopian tubal, be put into the culture dish for the M2 culture drop got ready in advance
In.
(4) ampulla is torn with syringe needle under stereomicroscope, it is multiple collects the fertilized eggs-cumulus cell released
It is fit.
(5) cell being collected into is transferred in hyaluronidase drop with mouth suction pipe, after 37 DEG C of 3~5min of digestion, is put
Enter in the KSOM drop balanced, 37 DEG C of incubations are incubated overnight, and guarantee the CO2 environment in incubator for 5%.
3. microinjection Cas9mRNA, gRNA, donor vector mixture
By mixed in equal amounts after the gRNA purified after synthesis, Cas9mRNA, donor vector dilution, it is mixed to draw a small amount of RNA
It closes object to be added in injection needle, syringe needle is packed on microinjection arm, takes the fertilized egg cell being incubated overnight in M2 culture medium
It washes to be placed on three times on microinjection platform and carries out microinjection.Successful fertilized egg cell will be injected, new KSOM training is put into
0.5h is cultivated in nutrient solution.
4. embryo transfer
(1) the heat ICR female mice for taking 6 week old, mates with the male mouse of ligation, chooses after next day fertilized egg cell's microinjection
Bolt carries out embryo transfer afternoon.
(2) ovum shifting tube is installed, the embryo after injecting in incubator is taken out, stand-by after three times are washed in M2 culture solution, sucking one
Quantitative M2 culture medium sucks air, then sucks the embryo for wanting Hui Zhi, then after sucking one section of air, sucks M2 culture medium, avoid rainbow
Suction effect controls the liquid outflow of ovum shifting tube.
(3) the ICR mouse for seeing bolt is selected, carries out intraperitoneal administration anesthesia by every kg body weight 5mg dosage after weighing.
(4) after female rat is lost consciousness, abdomen defeathering is carried on the back in Baoding of being lain on one's side, and alcohol disinfecting is placed on paper handkerchief.Body formula
Under microscope under last root rib cage of mouse one 1cm of incision of skin or so small wound.
(5) ovary and fallopian tubal position are found according to the anatomical physiology position of mouse, cuts off stomach wall, with elastic fatty tweezer
Adipose tissue is held, finds ampulla of uterine tube under stereomicroscope.
(6) ampulla of uterine tube is gently punctured with syringe needle, ovum shifting tube tip is pierced into ampulla, embryo is blown into
Tissue is backfilled after transplanting, is sewed up a wound by ampulla of uterine tube, same operation transplanting opposite side ampulla of uterine tube.
(7) female rat is placed on warm stage after it revives naturally, puts back to the letter such as mouse cage and record date, shifting ovum number
Breath.It is identified after its production.
The genotype identification of 5.F0 generation positive mouse
(1) it is individually raised after ICR receptor female mice embryo Hui Zhi, the sufficient gestation of water material after three weeks, observes farrowing situation
And make a record work.
(2) it after farrowing, is organized in every 0.5~1cm of mouse tail clip, the BufferTL1 solution of 400 μ L is added.
(3) the proteinase Protease Plus of 40 μ L is added into mixed liquor again, 65 DEG C of water-baths are more than half an hour,
Pay attention to mixing every 5 minutes primary.
(4) in managing after only surplus hair, bone 400 μ L Buffer TL2 solution are added, to be layered in pipe in digestion
Phenomenon is mixed by inversion.
(5) water-bath is adjusted to 65 DEG C, and water-bath 10min, 13400 × g are centrifuged 8min.
(6) supernatant is drawn to centrifugal column, and 13400 × g abandons liquid after being centrifuged 2min, avoids lower sediment sucking centrifugation as far as possible
In column.Liquid is abandoned after adding 500 μ L Buffer PW, 13400 × g centrifugation 1min.
(7) centrifugal column is washed with 700 μ L Buffer WB, abandons liquid after 13400 × g centrifugation 1min.
(8) it is washed again one time with 700 μ L Buffer WB.13400 × g sky is from 1min.
(9) it abandons underlying collection pipe and changes new 1.5mL EP pipe into, with 100 μ L Buffer EB, 13400 × g centrifugations
DNA is collected in 1min elution.
(10) recovered liquid is rejoined on pellosil, 13400 × g centrifugation 1min is eluted again.
(11) the genomic DNA concentration and OD260/280 value of microplate reader Detection and Extraction are used.
(12) it using the mouse tissue DNA of extraction as template, carries out PCR amplification and send sequencing.
6. obtaining F1 generation mouse
F0 is chosen to mate to obtain F1 generation mouse with wild type C57BL/6J mouse for positive mice.The identification of F1 generation murine genes
Method is identical for mouse as F0.
Four, experimental result
1. obtaining mouse situation
F0 obtains 16 for mouse, wherein 3 positive findings, F1 generation mouse obtains positive findings 10.
2. the genotype identification result of gene knock-in mouse
5 ' arm homologous recombination positive gene groups should amplify 5.5kb segment, and negative genes group is without product;3 ' arm homologous recombinations
Positive gene group should amplify 5.3kb segment, and negative genes group should amplify 11.1kb segment.The F0 of the both arms homologous recombination positive
It is 6,7, No. 8 for mouse, Long fragment PCR identifies that electrophoresis result is as shown in Figure 5.
Sequence table
<110>Shanghai Geriatric Institute of Chinese Medicine
<120>the gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh and its application
<130> /
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 8400
<212> DNA
<213> Mus musculus
<400> 1
taggacacac agccgacttc tctgtcctca aagcatcttt cccttagtgt tgccaagagc 60
ccccaggtgc tgataagtac catccctact ggcaatctcc agaagcagga gggggaggct 120
ggctgttgca gtcactgccc ctggagcccc tctgcagagg cccctgggtg acgtggccta 180
gccagaagac caatcacatg gccagcagga gcccagggac ccaagttgcc aagagtcccc 240
tttggcaggc agggtccgtc ctggggaggc tgtgacacag cacctccctc ctcatactct 300
tcttggactt caacagctgc ccctgcatag agtgctgggt tgggttgccc tccctcactt 360
taggtcctag ccagtggcct taggcagaga agccaggcct tgtgttgagg aaccctgttc 420
tgttgtgcac acacagcaca taacagcccc atcccttctg ttgcagtgac caagcagagg 480
gacacagaga tgggccagca gagcctgctg ttccaggtga ggtgggacca gtcaggggtg 540
gaccagacac acgggtggtg atgccaatag tgctgtgcat gttttacaga ttgactaccc 600
tgagatcgca gagggtatca tgccacgcca ccgtttcatg tctgcttatg agcagaggat 660
cgagcctcca gaccgccgct ggcagtacct gctcatggct gctgagccct atgagaccat 720
tgctttcaag gtagcgaccc tacaggacag agagagcagc taaattcagc tgtctgtgta 780
tcctagcccc tccttggggt gctgcagcct ctgactttct ccctaggtgc caagccggga 840
gattgacaag gctgagggca agttttggac ccactggaac agagaaacca agcaggtgag 900
gttccacagg ccttgcgtgg gtactctctc agcgctcctc agtggccctg ccccagtcac 960
tgaccctctc tcctacagtt ttttcttcag ttccacttta agatggagaa gcccccagca 1020
cctcccagcc tcccagcagg acccccaggc gtcaagcggc ccccgccccc actcatgaat 1080
ggactgcctc ctcgcccacc actccctgat gccttgcccc cacctccacc tggtggcctg 1140
cctctccctc ctatgccccc cactgggcct gctccctctg ggccccctgg acctccccag 1200
atgcccccac cagctcctgg ggtgcacccc ccggccccag tagtacaccc accaacatct 1260
ggagtccatc ccccagctcc tggggtacac cccccagcac cagtggtcca tccaccaaca 1320
tctggggtcc atcccccagc ccctggagtg cacccaccca cccctggagt gcacccacca 1380
gccccaggag tgcacccacc agctccaggt gtccacccac cagctccagg ggtacacccc 1440
ccaactccag gggtgcaccc accagctcca ggggtgcacc caccagctcc aggggtgcac 1500
ccaccagctc caggggtaca ccctcctcca tcagctggag ttcatcctca ggctccaggg 1560
gtacacccac ctgctcctgc agtacaccct caagcccctg gggtacaccc cccagcccct 1620
gggatccacc ctcaggcacc aggggttcac cctcagccgc ctcctggagt ccaccctgct 1680
gccccggggg tccaccctca gcctccaggg gttcacccct caaatcctgg ggtgcaccct 1740
gctcctatgc cccccatgct gaggccccca ctcccctcag atggccctgg gaacatgcct 1800
ccccctcccc caggcaactg agcagtcccc ccaccagcct ctgttgtctg tgtggtcttt 1860
tcccattgcc agtccttgga aggttttcta tttgtcctgc cttgagccta ttaaacagcc 1920
tcccccgtgt ctccctgtct gctgtgtgtt tggtagtggg gagggtggat actgcttgtc 1980
tctgttgaag ctgtggtgac ctggggcgtc ctccaggtgg gctccccagg gagatgggag 2040
ctactcaagg acagctcagg cctctgcagt tatgggccca gctctgagga cagaaagccc 2100
tttgagacag tcgcctccca cctgctgggc atgaaaagtg ccaggcactg tcccccaagg 2160
tcacctttgg tgttgatagg ggcgtccctc ccaagcaagc aatctggctc agccatacat 2220
ataagcaggg ccacccggac cttgctgtac caccgtacgt gatggactct gtctcagcgc 2280
ccatgatgcc ttgggactga gtgagttagg gcagaagctg ggggaggggg gtttggggga 2340
gggggcctcg ctggattgct aggcagaacc ttatacaccc tttcaggaac tgtagtgggc 2400
aagatggcag gacacacccc aatgatcaca ccttccagac agatgacagc agagctgctg 2460
tgtccttaca agcaaggtct ccacaccttg gatcagggtc cctcaggcct acatggcccc 2520
agaagatctc cagtgaagag tccagctgag ggaatttctg taggacagat cttgagggac 2580
tgaagctaat ggcctcagag actcagtcaa ccaatatttg cccacaggta ccagagactg 2640
gcatgggccc atcccctaac agccttctgg ttgaggttgt gccaaatgga agggttggtg 2700
gggttaggag tacacctggg aggctattcc cagtatggca ggggtggtgc ctgtagcctg 2760
accatcttcc ccagtcctgc tgacaagagt ccctgtgtcc acaggtaggt cctggcagag 2820
gggaggggac agagtggaag gaagctgccc ttaaccccag ccctcagcca gcacgtgccc 2880
accctctaca ggtgcgcaca gggatggagg aggaactggg acgttggagg gggtagttgg 2940
tccaccatag cctcttgtgc tcacagctgg cccacttcgt tctattccag aggaagcgga 3000
gctactaact tcagcctgct gaagcaggct ggagacgtgg aggagaaccc tggacctatg 3060
gtgcccaaga agaagaggaa agtctccaac ctgctgactg tgcaccaaaa cctgcctgcc 3120
ctccctgtgg atgccacctc tgatgaagtc aggaagaacc tgatggacat gttcagggac 3180
aggcaggcct tctctgaaca cacctggaag atgctcctgt ctgtgtgcag atcctgggct 3240
gcctggtgca agctgaacaa caggaaatgg ttccctgctg aacctgagga tgtgagggac 3300
tacctcctgt acctgcaagc cagaggcctg gctgtgaaga ccatccaaca gcacctgggc 3360
cagctcaaca tgctgcacag gagatctggc ctgcctcgcc cttctgactc caatgctgtg 3420
tccctggtga tgaggagaat cagaaaggag aatgtggatg ctggggagag agccaagcag 3480
gccctggcct ttgaacgcac tgactttgac caagtcagat ccctgatgga gaactctgac 3540
agatgccagg acatcaggaa cctggccttc ctgggcattg cctacaacac cctgctgcgc 3600
attgccgaaa ttgccagaat cagagtgaag gacatctccc gcaccgatgg tgggagaatg 3660
ctgatccaca ttggcaggac caagaccctg gtgtccacag ctggtgtgga gaaggccctg 3720
tccctggggg ttaccaagct ggtggagaga tggatctctg tgtctggtgt ggctgatgac 3780
cccaacaact acctgttctg ccgggtcaga aagaatggtg tggctgcccc ttctgccacc 3840
tcccaactgt ccacccgggc cctggaaggg atctttgagg ccacccaccg cctgatctat 3900
ggtgccaagg atgactctgg gcagagatac ctggcctggt ctggccactc tgccagagtg 3960
ggtgctgcca gggacatggc cagggctggt gtgtccatcc ctgaaatcat gcaggctggt 4020
ggctggacca atgtgaacat agtgatgaac tacatcagaa acctggactc tgagactggg 4080
gccatggtga ggctgctcga ggatggggac gtcagcgccc taataaagat cagcaaacac 4140
tcagctgggg tatctgtggg tggaggaaac tcctgtcaac ctcccttctg gaatgcaagg 4200
cctgagtcct tcccatccag cccctaactc ccgtgtgtcc ctctcacttt tctgatttca 4260
aaacaggatc tgtgtagccc tggtggtcct ggaactctaa ctcactcact ctcaccctct 4320
ctctcctctc tctgctctct cttctctctc tcttctctcc tctctcgacc agcttgcctc 4380
tgtctcccca gtgctaggat taaactcctg gaccctgtca ctttttaatt agttaattaa 4440
tttgttatgt gtggcgggga gagataggtg tctggccgga aggaagttaa agcaggagaa 4500
atgcttcaag tcagcctgaa attaaagagc aaaactgttt caaaaacagg ggagctggag 4560
aaatggctca gccccaaagg acacttgcac accccaacat acacgcgccc agatctttaa 4620
aagcaaaaca aacagccaag tatagcggtg cacacctgtc accccagcac tctggaggtg 4680
gacccaagag gatcaggact taaagccagg cttggttgca caggcttacg caggcgcata 4740
gggtacagat ggattgcaga aggcagaact aagtggagtt cattccgtgt gggtcgcgag 4800
atcgaactca ggcggtcagg cttggcagca agcgccttta cccatttcac tatctcaccg 4860
gccctatccc catctctgcg acccttaggg tccaggcaca aaggagtaga tgatcttgct 4920
gtcacaacac ggcctttatt tgctggtgct acagggagaa gggacacagg attcgcccag 4980
gggacacagg atcagtcacg ccccttccct cgcttctgtc tgggccggtc atcacggtca 5040
tgccttcgcc ggggagccca ggcctgcagc ttcccatgct cgaggaggtc cctggagtcc 5100
cgtccccatg gccgacggcc tccttcccgc gcctcccagc gccgtggcag tgattgacgg 5160
ggctccccag tgacctgtga cttatcctct ctcctcggct tctcccttct cggcttctcc 5220
ttcttcagtt tctccccttt acttggcttc tctttccgtg gcttctcctg ggaccctcgg 5280
tccccaaggg gtacgctctc ctccccagag gcttccgaga tggaccctcc acgttctacc 5340
cgggtttctg tagcttcagg gctcccggga agctcaggct catcctgcat ccgtgcctgg 5400
ggtggcccag gcttcggctg aggagacccg gatggagaca ccaaaaccgg aggcttaggc 5460
tgccaagaga caaagtgggg acttgggatc cgcgtgctca ggcctggtct ccttctccct 5520
tggtgagcag ccccatcagg tgaaatctct ggaaggaagg cttaccgctg gcgacgcttc 5580
cttctttggt ggagagctgg gcgggaccca tgggtgaggg gcagccacga cctccccagc 5640
cactgcgtct gaaaggcagg cagtctgaag tggaggaatg agcacagcca cccacctctt 5700
ctttgccctc acccccagaa ctccactggg ataccccaac ctcctcctag agacctctct 5760
tttttctctt tggagtggcc attccccgcc cccagctgca cgagggttgc tagcaataat 5820
aatcgtgggg gcgatcctct gctccaggat gaagtggaga acccttctcg gatggagtgg 5880
gaggacccgg ctcagtcgtg tatgtctgtc atcctggctg gaggaatgct gaggcacaag 5940
gattgccatg agacccaggc tagcttgtgc ctttgtaaag ggagcccttg attcaaaaca 6000
aaagccaggg cccaaggtat actcctgcca ttcctagatc ttgggaggtc aaagtaggga 6060
gggtcaggag accagcctaa gctacataga gaggttgagg tcttgagagt tttgtctttt 6120
ttctttcttt tttttttctt ttcttttttt ctttttcttt ttcttttctt ttcttttttt 6180
tttttttaag gtctggatgg tggtggcaca ctttccagca ttcaggaggg agagacaggc 6240
agagctctct aagtttgtgg ccagcctgga atatatattg gattccagcc agctagggct 6300
acatagtgag actctgtctc aaaatgaatg aatgaatgaa tgaatgaatg aatgaatgaa 6360
tgaaaagctc agaacatctg gaactaggcc tggttgtgaa acttaaggta gacaccataa 6420
aactaggagc taggtgtgac cgtgggcctc tcaggctggc ggactggcta ttccaggaat 6480
aggggcagag acgcttgagg ataaggtttg taggaacaga agagtcgcag cctgggcaag 6540
gctacaggga atgcccccaa cccctgtgga gaccctgtct tgtggagctc accccgacac 6600
agctgaagag ccgagcccag cagggccacc agcgaggcca gtaccaggca cttgttgagc 6660
gtcagatctc cccagggcag gtcatcgctt ggcgtccttg ggggcggctg caggggaggc 6720
gggggcggct gcaggggagg cggagcctgc ggcttcctac gtgcaggaac gatccggggg 6780
cctgaaggac aagcatggat ccgcctgtcg cctatggttc ctactccgtc ccagtgtgca 6840
gaccatcccc acctgctcac cctcccccga gcagacccac ttgttcccgc tttgccagct 6900
gtgctctcct tgcccgctag ctctttttcc atcttcttga gcccggcatc cccagcgcca 6960
gcagcaactg ggtcctgaag gacctgtagg gcatcggaga cagttccacg aggagtgtca 7020
gtccagaagt cctgtgggct gccatctcct tacaagtgag ttgtacagac tctgttatcc 7080
caaccctcag gaggatgagt caggaggatt gcttggagtt ggttgccagc ctgagtttca 7140
aagggagact ctgtctctaa aaatcaaaac ggaggagccc agccaagcag ctcagtgggt 7200
gactgcgctg cctacaaatc tgatagcttg agttggacac ccccacccct gacccacctt 7260
gtggaaggag aaaacagagt ctagggattt ggcatctgat ccctggctgt gcatgtgttc 7320
acacacacag acatcattat acatacacat acatacatac atacatacat acatacatac 7380
atacatacat acaaatgtgc atatatatgt atatacatat atactatact ggctggtttt 7440
gtctgtcaac ttgacacaag gtggagttat cacagagaaa ggagcctccc ttgaggaaat 7500
gcctctgaga gatccagctg taaggcattt tctcagttag taatcaagag gggagggccc 7560
actgtgggtg gtgccatccc tgggctatag tcttgagttc tataagaaag cgagctgagc 7620
aagccagggg aagcaaacca gtaagtaaca tccttccatg gcctctgcat cagctcctgc 7680
tttctgacct gcttgagttc cagtcctgac ttcctttgtg gaatgtggaa gtataagctg 7740
aataaatcct ttcctcccta acttgcttct tggtcatgat gtttgtgcag gaatagaaac 7800
cttgactaag acaacctcac acacacacat acatatatgt gtgaatacac agaagctgga 7860
gagacagcta agtagttaca gaaccagctg ctcctgcaga ggactcaggt tcgattccca 7920
gcacccacat gggactccag ctcctggtca gatgtctgca tctgacctct tcaggcatga 7980
ggaacacatg tgtgcaggcg aaactcataa aataaaaata aaatagaagt aagcattcat 8040
agacatcaac taaaaatgag ggaaagaagc cgggcggggt ggcacacgct tttaatccca 8100
gcactcagaa ggcagaggca ggcggatttc tgagttcgag gccagcctgg tctacaaagt 8160
gagttctggg acagccagag ttacacagag aaaccctgtc tcgaaaaaca aaaaaacaaa 8220
aatgagggaa agatttgtaa ggcctgtggg gctatagctc acccagcatg caggaagcca 8280
ggactctgtc cccagcatca cgtaagccag gtgtggggtc aggagggaaa ggcaggaggc 8340
tcagagttca ggatcatcct tgaggtttga atttgaggac agcctgggct atatgagacc 8400
<210> 2
<211> 408
<212> DNA
<213> Mus musculus
<400> 2
catcccggag acctaccaag ccaacaactg ccaaggcgcc tgcgcgtggc cgcagtctga 60
ccgtaatccg cgctacggga accacgtggt gctgctgcta aaaatgcagg ctcgcggggc 120
tgccctgggc cgcctgccct gctgcgtgcc cactgcctac gcgggcaagc tgctcatcag 180
cctgtccgag gagcgcatca gcgcgcacca cgtgcccaac atggtagcca ccgagtgcgg 240
ctgccggtga cgcccgccct cctcctcccc tccccccccc cccccgcccc cagtcagcgc 300
cctaataaag atcagcaaac actcagctgg ggtatctgtg ggtggaggaa actcctgtca 360
acctcccttc tggaatgcaa ggcctgagtc cttcccatcc agccccta 408
<210> 3
<211> 23
<212> DNA
<213> Mus musculus
<400> 3
aacatggtag ccaccgagtg ggg 23
<210> 4
<211> 23
<212> DNA
<213> Mus musculus
<400> 4
tcaccggcag ccgcactcgg tgg 23
Claims (10)
- The gene site-directed hybrid mice model building method for knocking in 2A-Cre of 1.Amh, which is characterized in that the construction method Are as follows: the gene site-directed hybrid mice model for knocking in 2A-Cre of Amh is constructed using CRISPR/Cas9 technology.
- 2. the gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh according to claim 1, feature It is, the murine genes for constructing obtained model are C57BL/6J-Amhem(2A-Cre)2Smoc, as shown in SEQ ID NO.1 Amino acid sequence.
- 3. the gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh, feature exist according to claim 1 In this method includes the following steps:(1) by way of in-vitro transcription, Cas9 mRNA and gRNA are obtained;(2) determine that site where the Amh gene on No. 5 and No. 3 chromosomes of mouse is site1 as shown in SEQ ID NO:1;The design recognition site of gRNA1 is designed as shown in SEQ ID NO:2 and SEQ ID NO:3;(3) expression vector of building expression gRNA1;Homologous recombination vector is constructed by the method for In-Fusion cloning (donor vector), the carrier include 4.7kb5 ' homology arm, 1.4kb2A-Cre-polyA and 4.3kb3 ' homology arm;(4) by the fertilized eggs of Cas9 mRNA, gRNA and vector supplier (donor vector) microinjection to C57BL/6J mouse In, F0 is obtained for mouse, is identified through Long fragment PCR, obtains the F0 of 3 correct homologous recombinations altogether for mouse;(5) F0 for mouse and C57BL/6J mouse (the mouse strain of nineteen twenty-one Little Abby Lathrop, female mice 57 C57BL obtained by mating with male mice 52 is " standard " inbred mouse) the positive F1 generation mouse of mating acquisition 10.
- 4. the gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh, feature exist according to claim 1 In obtained F1 generation mouse is C57BL/6J-Amhem(2A-Cre)2Smoc。
- 5. the gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh, feature exist according to claim 1 In result is transcribed in vitro in step (1) Cas9 and gRNA are as follows:GRNA sequence (5 ' -3 ')gRNA1 AACATGGTAGCCACCGAGTG GGGgRNA2 TCACCGGCAGCCGCACTCGG TGG;Cas9, gRNA electrophoresis result is transcribed in vitro are as follows:The homologous recombination plasmid map that step (3) the homologous recombination plasmid construction obtains:Electrophoretogram is identified in homologous recombination vector digestion.B:BamHI digestion qualification result, theoretical stripe size be 9.1kb, 5.8kb, 1.3kb;M:1kb DNA ladder;Electrophoretogram is identified in homologous recombination vector digestion.B:BamHI digestion qualification result, theoretical stripe size be 9.1kb, 5.8kb, 1.3kb;M:1kb DNA ladder;Homologous recombination positive mice PCR qualification program:5 ' arm homologous recombination positive gene groups should amplify 5.5kb segment, and negative genes group is without product;3 ' arm homologous recombinations are positive Genome should amplify 5.3kb segment, and negative genes group should amplify 11.1kb segment.
- 6. the gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh, feature exist according to claim 1 In step (4) F0 includes the following steps: for the identification of murine genes typeThrough fertilized eggs microinjection, the present invention obtains 16 F0 for mouse altogether.By way of Long fragment PCR, to F0 for mouse Genotype identified that PCR result confirms that the project obtains the positive F0 of 3 correct homologous recombinations for mouse altogether through sequencing;Homologous recombination positive mice PCR qualification program: 5 ' arm homologous recombination positive gene groups should amplify 5.5kb segment, negative Genome is without product;3 ' arm homologous recombination positive gene groups should amplify 5.3kb segment, and negative genes group should amplify 11.1kb Segment;Homology arm recombinates positive F0 for mouse PCR identification method:Primer sequence 5'-- > 3' Primer typeI CTCCTTTCTCTTTGCAGGGG ForwardII GCATCTTCCAGGTGTGTTCA Reverse;Reaction system:* PrimeStar GXL (TaKaRa, Code No:R050A);Reaction condition:Homology arm recombinates positive F0 for mouse PCR identification method:Primer sequence 5'-- > 3' Primer typeIII TGTGTGCTCTGGGAATGACC ForwardIV AAGAGTGACAGCCAGAAGCC Reverse;Reaction system:* PrimeStar GXL (TaKaRa, Code No:R050A);Reaction condition:Homologous recombination positive F0 is for mouse PCR qualification result: 6,7,8 be the positive.
- 7. the gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh, feature exist according to claim 1 In step (5) the F1 generation mouse obtains and genotype identification includes the following steps:F0 mates for positive mice with wild type C57BL/6J mouse, and breeding obtains F1 generation mouse.It identifies and is sequenced through PCR and is true Recognize, obtains positive F1 generation mouse 3, number are as follows: 2,3, No. 4 altogether;5 ' and 3 ' homology arm PCR of F1 generation mouse identificationPCR identification method identifies part for mouse with F0,5 ' and 3 ' homology arm PCR of F1 generation mouse identification electrophoresis result: 2,3,4, No. 10,11,13,14,15,16,22 mouse are the positive;F1 generation mouse PCR identification sequencing comparison result: No. 2,3,4,10,11,13,14,15,16,22 mouse are the positive.
- 8. the gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh, feature exist according to claim 1 In application of the mouse model that the construction method obtains in screening preparation detection/treatment reproductive development disease medicament.
- 9. the construction method of the gene site-directed hybrid mice model for knocking in 2A-Cre of Amh according to claim 1, feature It is, application of the mouse model that the construction method obtains in screening preparation detection/treatment disease of ovary drug.
- 10. the construction method of the gene site-directed hybrid mice model for knocking in 2A-Cre of Amh according to claim 1, special Sign is that the mouse model that the construction method obtains is in screening preparation detection/treatment gonad granulocyte aging and apoptosis Application in disease medicament.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910240778.2A CN109943564B (en) | 2019-03-28 | 2019-03-28 | Construction method and application of hybrid mouse model with Amh gene fixed-point knock-in 2A-Cre |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910240778.2A CN109943564B (en) | 2019-03-28 | 2019-03-28 | Construction method and application of hybrid mouse model with Amh gene fixed-point knock-in 2A-Cre |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109943564A true CN109943564A (en) | 2019-06-28 |
CN109943564B CN109943564B (en) | 2022-03-15 |
Family
ID=67012122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910240778.2A Active CN109943564B (en) | 2019-03-28 | 2019-03-28 | Construction method and application of hybrid mouse model with Amh gene fixed-point knock-in 2A-Cre |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109943564B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110923265A (en) * | 2019-12-19 | 2020-03-27 | 上海同科生物科技有限公司 | Construction method of mouse model for conditionally overexpressing HPV E7 gene at H11 site |
CN111500628A (en) * | 2020-04-15 | 2020-08-07 | 徐州医科大学 | Construction method and application of CD8 site-directed gene knock-in 2A-CreERT2-Wpre-pA mouse model |
CN112239767A (en) * | 2020-09-24 | 2021-01-19 | 中国人民解放军军事科学院军事医学研究院 | Construction method and application of mouse model for non-destructive monitoring of neuroinflammation by breaking through skull limitation |
CN112997966A (en) * | 2021-03-08 | 2021-06-22 | 国家卫生健康委科学技术研究所 | Mouse model knocking-in miRNA-125a based on CRISPR/Cas9 technology and construction method |
CN114214360A (en) * | 2021-12-27 | 2022-03-22 | 西安英创生物技术有限公司 | Congenital myasthenia gravis mouse model, and construction method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106480099A (en) * | 2016-10-21 | 2017-03-08 | 赣南医学院第附属医院 | The H11 fixed point of conditionality overexpression Spp1 gene knocks in hybrid mice model and its construction method |
US20170191030A1 (en) * | 2014-05-16 | 2017-07-06 | Koninklijke Nederlandse Akademie Van Wetenschappen | Improved culture method for organoids |
CN108884472A (en) * | 2016-01-26 | 2018-11-23 | 西达-赛奈医疗中心 | The system and method and its disease model of cassete exchange (dRMCE) for internal double recombinase-mediateds |
-
2019
- 2019-03-28 CN CN201910240778.2A patent/CN109943564B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170191030A1 (en) * | 2014-05-16 | 2017-07-06 | Koninklijke Nederlandse Akademie Van Wetenschappen | Improved culture method for organoids |
CN108884472A (en) * | 2016-01-26 | 2018-11-23 | 西达-赛奈医疗中心 | The system and method and its disease model of cassete exchange (dRMCE) for internal double recombinase-mediateds |
CN106480099A (en) * | 2016-10-21 | 2017-03-08 | 赣南医学院第附属医院 | The H11 fixed point of conditionality overexpression Spp1 gene knocks in hybrid mice model and its construction method |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110923265A (en) * | 2019-12-19 | 2020-03-27 | 上海同科生物科技有限公司 | Construction method of mouse model for conditionally overexpressing HPV E7 gene at H11 site |
CN111500628A (en) * | 2020-04-15 | 2020-08-07 | 徐州医科大学 | Construction method and application of CD8 site-directed gene knock-in 2A-CreERT2-Wpre-pA mouse model |
CN112239767A (en) * | 2020-09-24 | 2021-01-19 | 中国人民解放军军事科学院军事医学研究院 | Construction method and application of mouse model for non-destructive monitoring of neuroinflammation by breaking through skull limitation |
CN112239767B (en) * | 2020-09-24 | 2022-04-15 | 中国人民解放军军事科学院军事医学研究院 | Construction method and application of mouse model for non-destructive monitoring of neuroinflammation by breaking through skull limitation |
CN112997966A (en) * | 2021-03-08 | 2021-06-22 | 国家卫生健康委科学技术研究所 | Mouse model knocking-in miRNA-125a based on CRISPR/Cas9 technology and construction method |
CN114214360A (en) * | 2021-12-27 | 2022-03-22 | 西安英创生物技术有限公司 | Congenital myasthenia gravis mouse model, and construction method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN109943564B (en) | 2022-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109943564A (en) | The gene site-directed hybrid mice model building method for knocking in 2A-Cre of Amh and its application | |
CN109943593A (en) | Mir3061 gene Rosa26 fixed point knocks in hybrid mice model building method and application | |
CN111549072B (en) | VISTA gene humanized animal cell, animal model construction method and application | |
CN107858373A (en) | Endothelial cell conditionity knocks out the construction method of CCR5 genetic mouse models | |
CN109266656A (en) | A kind of construction method of PD1 humanization BALB/c mouse model and its application | |
CN110055223A (en) | A kind of preparation method and applications of the immunodeficient animals of B2m genetic modification | |
CN111485002A (en) | Preparation method and application of transgenic mouse with severe immunodeficiency | |
CN109929875B (en) | Construction method and application of LAG3 gene humanized animal model | |
CN112251463B (en) | Construction method of CD73 humanized mouse model | |
CN108018310B (en) | Construction method and application of inducible transgenic mouse cardiomyopathy animal model | |
CN113699152A (en) | Construction method and application of SLC35E2B gene knockout mouse animal model | |
CN116250509B (en) | Construction method and application of SIGLEC10 humanized mouse model | |
CN110195057B (en) | Preparation method and application of genetically modified non-human animal or progeny thereof with Hr gene | |
CN115044619B (en) | Construction method of whole-body inducible Ppp3ca gene knockout mouse model | |
CN114134183B (en) | Construction method and application of SIGLEC15 gene humanized animal model | |
CN111109199A (en) | Slc12a9 gene knockout mouse model and establishment method and application thereof | |
CN113355355B (en) | Construction method and application of IL23A and/or IL12B gene humanized non-human animal | |
CN110592122B (en) | Zebra fish naalad2 gene promoter and application thereof | |
CN114134152A (en) | GLP1R gene humanized non-human animal and construction method and application thereof | |
CN109694885B (en) | Method for preparing PI3K gamma whole-body knockout mode mouse based on CRISPR/Cas9 technology, application thereof and kit | |
CN108239642A (en) | A kind of relevant long non-coding RNA of Adipocyte Differentiation and its application | |
CN101519664B (en) | Method for breeding genetically modified animal by using recombinant adenovirus vector | |
CN112626122A (en) | hKDR humanized mouse model and establishing method and application thereof | |
CN111019972A (en) | Construction method and application of CD27 humanized mouse model | |
CN104059887A (en) | Application of long non-coding RNA (ribonucleic acid) Ovo12-AS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |